Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder

Positive Aggregate Safety Data From Vafidemstat’s Ongoing Phase IIb PORTICO Trial in Borderline Personality Disorder &nbsp Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients. PORTICO plans to recruit 188 patients. &nbsp MADRID, Spain and BOSTON, July 05, 2023 (GLOBE NEWSWIRE) -- ..